BETHLEHEM, Pa., Oct. 27, 2021 (GLOBE NEWSWIRE) — OraSure Technologies, Inc. (NASDAQ: OSUR) has scheduled its regular earnings conference call covering 2021 third quarter financial results and certain business developments for 5:00 pm ET (2:00 pm PT) on Wednesday, November 3, 2021.
November 3, 2021 Schedule:
4:01 p.m. ET – 2021 third quarter financial results press release will be distributed.
4:50 p.m. ET – To participate in the conference call, dial (888) 771-4371 (Domestic) or (847) 585-4405 (International) and reference Conference ID # 50214426.
5:00 p.m. ET – Conference call and simultaneous Webcast begins.
The conference call will also be available via webcast, and may be accessed on the Investor Relations page of OraSure’s website, www.orasure.com. Please click on the webcast link and follow the prompts for registration and access, 10 minutes prior to the call.
If you are unable to participate, a replay of the call will be archived on OraSure’s website shortly after the call has ended and will be available for 14 days. A replay of the call can also be accessed until midnight, November 17, 2021 by dialing (855) 859-2056 (Domestic) or (404) 537-3406 (International) and entering the Conference ID # 50214426.
| Investor Contact: | Media Contact: | |
| Scott Gleason | Amy Koch | |
| Interim CFO & SVP Investor Relations & Corp. Communications | Sr. Mgr. Corporate Communications | |
| 484-425-0588 | 484-523-1815 | |
| sgleason@orasure.com | media@orasure.com |
After President Trump's Marijuana Executive Order, Will the DEA Act-or Be Compelled by the Courts?"Despite…
Boards and executive buyers are raising the 2026 bar for all product and service rankings…
Boards and executive buyers are raising the 2026 bar for all product and service rankings…
Tampa based Celebrity Board-Certified Plastic Surgeon Dr. Meegan Gruber expands an interactive approach that allows…
Clemson University and Nordic Wellness have launched a pioneering partnership tackling the student mental health…
Telehealth Platform Offers Compounded GLP-1 Injections and Oral Tablets at $299/Month With No Contract as…